Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Lung Cancer Diagnostics Market
Introduction
The global lung cancer diagnostics market includes a range of tools and technologies aimed at detecting lung cancer, including imaging, biomarker testing, and biopsy methods. Lung cancer, among the most common and lethal cancers worldwide, necessitates advanced diagnostic techniques for early detection to improve patient outcomes and survival rates. This market has grown significantly, driven by increased awareness of the importance of early screening, particularly for high-risk populations such as smokers. Additionally, advances in diagnostic imaging and molecular testing have transformed the way lung cancer is identified and characterized. The market size has expanded due to technological advancements and an increase in global cancer incidence. Currently, the market includes several diagnostic solutions that target various types of lung cancer, including non-small cell lung cancer (NSCLC), providing valuable tools for healthcare providers worldwide.
Segmentation
By Technology Type
Imaging
X-ray Imaging
Computed Tomography (CT) Scans
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET) Scans
Others
Biomarker Testing
Genetic Biomarkers
EGFR Mutation Testing
ALK Mutation Testing
Protein Biomarkers
ProGRP Biomarkers
CEA Biomarkers
Others
Biopsy Techniques
Needle Biopsy
Bronchoscopy
Liquid Biopsy
Other Diagnostic Methods
By Cancer Type
Non-Small Cell Lung Cancer (NSCLC)
Adenocarcinoma
Squamous Cell Carcinoma
Large Cell Carcinoma
Small Cell Lung Cancer (SCLC)
Limited-Stage SCLC
Extensive-Stage SCLC
By End-User
Hospitals and Clinics
Government Hospitals
Private Clinics
Diagnostic Laboratories
Independent Laboratories
Hospital-Based Laboratories
Academic and Research Institutes
By Distribution Channel
Retail Pharmacies
Standalone Pharmacies
Chain Pharmacies
Online Pharmacies
E-Commerce Platforms
Health Portals
By Geography
North America United States Canada
Europe Germany France United Kingdom
Rest of Europe
Asia Pacific China Japan India
Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
List of Market Players
Roche Diagnostics (Switzerland)
Thermo Fisher Scientific (United States)
Qiagen (Germany)
Abbott Laboratories (United States)
Siemens Healthineers (Germany)
Agilent Technologies (United States)
Illumina, Inc. (United States)
Bio-Rad Laboratories, Inc. (United States)
GE Healthcare (United States)
PerkinElmer, Inc. (United States)
BD Diagnostics (United States)
Hologic, Inc. (United States)
AstraZeneca plc (United Kingdom)
Bristol-Myers Squibb (United States)
Canon Medical Systems Corporation (Japan)
Drivers
The global lung cancer diagnostics market is driven by a combination of factors, including the high incidence rate of lung cancer, especially in regions with significant tobacco usage and pollution levels. Growing awareness regarding early detection and preventive healthcare is boosting demand for advanced diagnostic solutions, such as low-dose CT scans and biomarker-based tests. Technological advancements have enabled the development of more accurate and non-invasive diagnostic techniques, including liquid biopsies and molecular diagnostics, which are increasingly utilized in clinical settings. Furthermore, the aging global population is contributing to an increase in lung cancer cases, driving up the demand for effective screening and diagnostic solutions. Government initiatives focused on reducing cancer mortality rates also support market growth, as screening programs become more accessible. Collaborations between research institutions and healthcare companies aim to create innovative diagnostic tools, adding further impetus to the market's expansion.
Restraints
Despite the robust growth trajectory, the global lung cancer diagnostics market faces challenges, including high diagnostic costs and limited accessibility in low-income regions. The high cost of advanced imaging and biomarker tests can limit adoption, particularly among patients without adequate health insurance. Additionally, lung cancer diagnostics often require sophisticated equipment and skilled professionals, making them less accessible in rural and underdeveloped regions. Some tests also carry a risk of false positives or negatives, leading to concerns over their reliability. In certain countries, regulatory constraints also slow down the approval of new diagnostic technologies, hindering market expansion. Moreover, awareness and education about lung cancer screening remain low in many regions, especially among populations without regular access to healthcare, limiting the adoption of early detection methods.
Opportunity
There are significant growth opportunities in the global lung cancer diagnostics market, particularly with the rise of precision medicine and personalized diagnostic approaches. The growing interest in liquid biopsies offers a non-invasive option that holds considerable promise, especially in populations reluctant to undergo traditional biopsy procedures. Emerging markets in Asia-Pacific and Latin America also represent a lucrative opportunity, as government initiatives focus on strengthening healthcare infrastructure and early cancer detection programs. Additionally, advancements in artificial intelligence and machine learning have enabled more accurate imaging interpretation, which could enhance diagnostic accuracy in lung cancer detection. Collaborative partnerships between technology companies and healthcare providers are leading to new solutions that integrate diagnostic tools with digital health platforms, further expanding accessibility. As consumer awareness increases, demand for early and accurate diagnostics will drive further innovation and investment in this sector.
Trend
A major trend in the global lung cancer diagnostics market is the shift towards non-invasive diagnostic tools, such as liquid biopsies, which use blood samples to detect cancer biomarkers. This technique is gaining popularity for its ability to provide rapid, accurate results with minimal discomfort to the patient. The integration of AI and machine learning into diagnostic imaging is also revolutionizing the industry, improving the accuracy and efficiency of lung cancer detection through advanced image analysis. Moreover, the rise of molecular diagnostics, such as genomic testing for mutations in the EGFR and ALK genes, has enabled more targeted treatment options for patients with non-small cell lung cancer. Another trend is the increased adoption of point-of-care diagnostic solutions, allowing for faster and more accessible testing outside of traditional hospital settings. As demand grows for precision diagnostics, companies are also investing in biomarker discovery to facilitate personalized treatment approaches.
Key Target Audience
Hospitals and Oncology Clinics
Diagnostic Laboratories
Research Institutes
Pharmaceutical and Biotech Companies
Healthcare Policy Makers
Medical Device Distributors
Cancer Screening Program Providers
FAQs about the Global Lung Cancer Diagnostics Market
It refers to the market for tools and technologies used to detect lung cancer, including imaging, biomarker tests, and biopsy methods.
The market is driven by rising cancer incidence, technological advancements, and increased awareness of early screening.
Key methods include imaging (CT scans, MRI), biomarker testing, and biopsy techniques.
Challenges include high diagnostic costs, limited access in rural areas, and regulatory constraints in some regions.
Non-invasive diagnostics, AI-enhanced imaging, and precision diagnostics are key trends in the industry.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis 2. Market Dashboard 3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Technology Type 3.2.2 By Cancer Type 3.2.3 By End-User 3.2.4 By Distribution Channel 3.2.5 By Geography 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges 4. Global Lung Cancer Diagnostics Market by Technology Type 4.1 Introduction 4.2 Market Size and Growth Rate by Technology Type (2024-2030) 4.2.1 Imaging 4.2.1.1 X-ray Imaging 4.2.1.2 Computed Tomography (CT) Scans 4.2.1.3 Magnetic Resonance Imaging (MRI) 4.2.1.4 Positron Emission Tomography (PET) Scans 4.2.1.5 Others 4.2.2 Biomarker Testing 4.2.2.1 Genetic Biomarkers 4.2.2.1.1 EGFR Mutation Testing 4.2.2.1.2 ALK Mutation Testing 4.2.2.2 Protein Biomarkers 4.2.2.2.1 ProGRP Biomarkers 4.2.2.2.2 CEA Biomarkers 4.2.2.3 Others 4.2.3 Biopsy Techniques 4.2.3.1 Needle Biopsy 4.2.3.2 Bronchoscopy 4.2.3.3 Liquid Biopsy 4.2.4 Other Diagnostic Methods 5. Global Lung Cancer Diagnostics Market by Cancer Type 5.1 Introduction 5.2 Market Size and Growth Rate by Cancer Type (2024-2030) 5.2.1 Non-Small Cell Lung Cancer (NSCLC) 5.2.1.1 Adenocarcinoma 5.2.1.2 Squamous Cell Carcinoma 5.2.1.3 Large Cell Carcinoma 5.2.2 Small Cell Lung Cancer (SCLC) 5.2.2.1 Limited-Stage SCLC 5.2.2.2 Extensive-Stage SCLC 6. Global Lung Cancer Diagnostics Market by End-User 6.1 Introduction 6.2 Market Size and Growth Rate by End-User (2024-2030) 6.2.1 Hospitals and Clinics 6.2.1.1 Government Hospitals 6.2.1.2 Private Clinics 6.2.2 Diagnostic Laboratories 6.2.2.1 Independent Laboratories 6.2.2.2 Hospital-Based Laboratories 6.2.3 Academic and Research Institutes 7. Global Lung Cancer Diagnostics Market by Distribution Channel 7.1 Introduction 7.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 7.2.1 Retail Pharmacies 7.2.1.1 Standalone Pharmacies 7.2.1.2 Chain Pharmacies 7.2.2 Online Pharmacies 7.2.2.1 E-Commerce Platforms 7.2.2.2 Health Portals 8. Global Lung Cancer Diagnostics Market by Geography 8.1 Introduction 8.2 Market Size and Growth Rate by Region (2024-2030) 8.2.1 North America 8.2.1.1 United States 8.2.1.2 Canada 8.2.2 Europe 8.2.2.1 Germany 8.2.2.2 France 8.2.2.3 United Kingdom 8.2.2.4 Rest of Europe 8.2.3 Asia Pacific 8.2.3.1 China 8.2.3.2 Japan 8.2.3.3 India 8.2.3.4 Southeast Asia 8.2.3.5 Rest of Asia Pacific 8.2.4 Latin America 8.2.4.1 Brazil 8.2.4.2 Rest of Latin America 8.2.5 Middle East & Africa (MEA) 8.2.5.1 GCC 8.2.5.2 North Africa 8.2.5.3 South Africa 8.2.5.4 Rest of Middle East & Africa 9. Competitive Landscape 9.1 Company Profiles 9.1.1 Roche Diagnostics (Switzerland) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.2 Thermo Fisher Scientific (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.3 Qiagen (Germany) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.4 Abbott Laboratories (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.5 Siemens Healthineers (Germany) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.6 Agilent Technologies (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.7 Illumina, Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.8 Bio-Rad Laboratories, Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.9 GE Healthcare (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.10 PerkinElmer, Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.11 BD Diagnostics (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.12 Hologic, Inc. (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.13 AstraZeneca plc (United Kingdom) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.14 Bristol-Myers Squibb (United States) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 9.1.15 Canon Medical Systems Corporation (Japan) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 10. List of Tables and Figure Tables Table Global Lung Cancer Diagnostics Market Size by Technology Type (2024-2030) Table Imaging Market Size by Sub-type (2024-2030) Table Biomarker Testing Market Size by Sub-type (2024-2030) Table Genetic Biomarkers Market Size by Sub-type (2024-2030) Table Protein Biomarkers Market Size by Sub-type (2024-2030) Table Biopsy Techniques Market Size by Sub-type (2024-2030) Table Global Lung Cancer Diagnostics Market Size by Cancer Type (2024-2030) Table Non-Small Cell Lung Cancer (NSCLC) Market Size by Sub-type (2024-2030) Table Small Cell Lung Cancer (SCLC) Market Size by Sub-type (2024-2030) Table Global Lung Cancer Diagnostics Market Size by End-User (2024-2030) Table Hospitals and Clinics Market Size by Sub-type (2024-2030) Table Diagnostic Laboratories Market Size by Sub-type (2024-2030) Table Global Lung Cancer Diagnostics Market Size by Distribution Channel (2024-2030) Table Retail Pharmacies Market Size by Sub-type (2024-2030) Table Online Pharmacies Market Size by Sub-type (2024-2030) Figures Figure Global Lung Cancer Diagnostics Market Size and Growth Rate by Technology Type (2024-2030) Figure Imaging Market Growth Rate by Sub-type (2024-2030) Figure Biomarker Testing Market Growth Rate by Sub-type (2024-2030) Figure Genetic Biomarkers Market Growth Rate by Sub-type (2024-2030) Figure Protein Biomarkers Market Growth Rate by Sub-type (2024-2030) Figure Biopsy Techniques Market Growth Rate by Sub-type (2024-2030) Figure Global Lung Cancer Diagnostics Market Size and Growth Rate by Cancer Type (2024-2030) Figure Non-Small Cell Lung Cancer (NSCLC) Market Growth Rate by Sub-type (2024-2030) Figure Small Cell Lung Cancer (SCLC) Market Growth Rate by Sub-type (2024-2030) Figure Global Lung Cancer Diagnostics Market Size and Growth Rate by End-User (2024-2030) Figure Hospitals and Clinics Market Growth Rate by Sub-type (2024-2030) Figure Diagnostic Laboratories Market Growth Rate by Sub-type (2024-2030) Figure Global Lung Cancer Diagnostics Market Size and Growth Rate by Distribution Channel (2024-2030) Figure Retail Pharmacies Market Growth Rate by Sub-type (2024-2030) Figure Online Pharmacies Market Growth Rate by Sub-type (2024-2030) Table Global Lung Cancer Diagnostics Market by Regions (2022-2024) Table Global Lung Cancer Diagnostics Market by Regions (2024-2030) Figure North America Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table North America Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table North America Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table North America Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table North America Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table North America Global Lung Cancer Diagnostics Market by End User (2022-2024) Table North America Global Lung Cancer Diagnostics Market by End User (2024-2030) Table North America Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table North America Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Table North America Global Lung Cancer Diagnostics Market by Country (2022-2024) Table North America Global Lung Cancer Diagnostics Market by Country (2024-2030) Figure United States Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table United States Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table United States Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table United States Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table United States Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table United States Global Lung Cancer Diagnostics Market by End User (2022-2024) Table United States Global Lung Cancer Diagnostics Market by End User (2024-2030) Table United States Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table United States Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Canada Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Canada Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Canada Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Canada Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Canada Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Canada Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Canada Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Canada Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Canada Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Europe Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Europe Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Europe Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Europe Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Europe Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Europe Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Europe Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Europe Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Europe Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Table Europe Global Lung Cancer Diagnostics Market by Country (2022-2024) Table Europe Global Lung Cancer Diagnostics Market by Country (2024-2030) Figure Germany Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Germany Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Germany Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Germany Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Germany Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Germany Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Germany Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Germany Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Germany Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure France Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table France Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table France Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table France Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table France Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table France Global Lung Cancer Diagnostics Market by End User (2022-2024) Table France Global Lung Cancer Diagnostics Market by End User (2024-2030) Table France Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table France Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure United Kingdom UK Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table United Kingdom UK Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table United Kingdom UK Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table United Kingdom UK Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table United Kingdom UK Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table United Kingdom UK Global Lung Cancer Diagnostics Market by End User (2022-2024) Table United Kingdom UK Global Lung Cancer Diagnostics Market by End User (2024-2030) Table United Kingdom UK Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table United Kingdom UK Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Russia Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Russia Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Russia Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Russia Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Russia Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Russia Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Russia Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Russia Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Russia Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Italy Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Italy Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Italy Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Italy Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Italy Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Italy Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Italy Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Italy Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Italy Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Rest of Europe Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Rest of Europe Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Rest of Europe Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Rest of Europe Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Rest of Europe Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Rest of Europe Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Rest of Europe Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Rest of Europe Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Rest of Europe Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Asia-Pacific Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Asia-Pacific Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Asia-Pacific Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Asia-Pacific Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Asia-Pacific Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Country (2022-2024) Table Asia-Pacific Global Lung Cancer Diagnostics Market by Country (2024-2030) Figure China Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table China Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table China Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table China Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table China Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table China Global Lung Cancer Diagnostics Market by End User (2022-2024) Table China Global Lung Cancer Diagnostics Market by End User (2024-2030) Table China Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table China Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Japan Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Japan Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Japan Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Japan Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Japan Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Japan Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Japan Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Japan Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Japan Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Korea Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Korea Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Korea Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Korea Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Korea Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Korea Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Korea Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Korea Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Korea Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure India Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table India Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table India Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table India Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table India Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table India Global Lung Cancer Diagnostics Market by End User (2022-2024) Table India Global Lung Cancer Diagnostics Market by End User (2024-2030) Table India Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table India Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Southeast Asia Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Southeast Asia Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Southeast Asia Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Southeast Asia Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Southeast Asia Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Southeast Asia Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Southeast Asia Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Southeast Asia Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Southeast Asia Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Rest of Asia-Pacific Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Rest of Asia-Pacific Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Latin America Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Latin America Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Latin America Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Latin America Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Latin America Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Latin America Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Latin America Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Latin America Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Latin America Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Table Latin America Global Lung Cancer Diagnostics Market by Country (2022-2024) Table Latin America Global Lung Cancer Diagnostics Market by Country (2024-2030) Figure Brazil Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Brazil Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Brazil Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Brazil Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Brazil Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Brazil Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Brazil Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Brazil Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Brazil Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Mexico Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Mexico Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Mexico Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Mexico Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Mexico Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Mexico Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Mexico Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Mexico Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Mexico Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Columbia Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Columbia Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Columbia Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Columbia Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Columbia Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Columbia Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Columbia Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Columbia Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Columbia Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Rest of Latin America Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Rest of Latin America Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Rest of Latin America Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Rest of Latin America Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Rest of Latin America Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Rest of Latin America Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Rest of Latin America Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Rest of Latin America Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Rest of Latin America Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Middle East and Africa Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Middle East and Africa Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Middle East and Africa Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Middle East and Africa Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Middle East and Africa Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Table Middle East and Africa Global Lung Cancer Diagnostics Market by Country (2024-2030) Figure Saudi Arabia Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Saudi Arabia Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Saudi Arabia Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Saudi Arabia Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Saudi Arabia Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Saudi Arabia Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Saudi Arabia Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Saudi Arabia Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Saudi Arabia Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure United Arab Emirates Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table United Arab Emirates Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table United Arab Emirates Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table United Arab Emirates Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table United Arab Emirates Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table United Arab Emirates Global Lung Cancer Diagnostics Market by End User (2022-2024) Table United Arab Emirates Global Lung Cancer Diagnostics Market by End User (2024-2030) Table United Arab Emirates Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table United Arab Emirates Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure South Africa Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table South Africa Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table South Africa Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table South Africa Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table South Africa Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table South Africa Global Lung Cancer Diagnostics Market by End User (2022-2024) Table South Africa Global Lung Cancer Diagnostics Market by End User (2024-2030) Table South Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table South Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030) Figure Rest of Middle East and Africa Global Lung Cancer Diagnostics Market Size and Growth Rate (2024-2030) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by By Technology Type(2022-2024) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by By Technology Type(2024-2030) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by Cancer Type (2022-2024) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by Cancer Type (2024-2030) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by End User (2022-2024) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by End User (2024-2030) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2022-2024) Table Rest of Middle East and Africa Global Lung Cancer Diagnostics Market by Distribution Channel (2024-2030)
Tables Financial Overview of Key Companies Table Roche Diagnostics Lung Cancer Diagnostics Financial Overview Table Thermo Fisher Scientific Lung Cancer Diagnostics Financial Overview Table Qiagen Lung Cancer Diagnostics Financial Overview Table Abbott Laboratories Lung Cancer Diagnostics Financial Overview Table Siemens Healthineers Lung Cancer Diagnostics Financial Overview Table Agilent Technologies Lung Cancer Diagnostics Financial Overview Table Illumina, Inc. Lung Cancer Diagnostics Financial Overview Table Bio-Rad Laboratories, Inc. Lung Cancer Diagnostics Financial Overview Table GE Healthcare Lung Cancer Diagnostics Financial Overview Table PerkinElmer, Inc. Lung Cancer Diagnostics Financial Overview Table BD Diagnostics Lung Cancer Diagnostics Financial Overview Table Hologic, Inc. Lung Cancer Diagnostics Financial Overview Table AstraZeneca plc Lung Cancer Diagnostics Financial Overview Table Bristol-Myers Squibb Lung Cancer Diagnostics Financial Overview Table Canon Medical Systems Corporation Lung Cancer Diagnostics Financial Overview
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Global Lung Cancer Diagnostics Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Lung Cancer Diagnostics Market for the past year and forecasts for the next six years. Global Lung Cancer Diagnostics Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Global Lung Cancer Diagnostics Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Global Lung Cancer Diagnostics Market from different application industries in different regions.
Segmentation
By Technology Type
Imaging
X-ray Imaging
Computed Tomography (CT) Scans
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET) Scans
Others
Biomarker Testing
Genetic Biomarkers
EGFR Mutation Testing
ALK Mutation Testing
Protein Biomarkers
ProGRP Biomarkers
CEA Biomarkers
Others
Biopsy Techniques
Needle Biopsy
Bronchoscopy
Liquid Biopsy
Other Diagnostic Methods
By Cancer Type
Non-Small Cell Lung Cancer (NSCLC)
Adenocarcinoma
Squamous Cell Carcinoma
Large Cell Carcinoma
Small Cell Lung Cancer (SCLC)
Limited-Stage SCLC
Extensive-Stage SCLC
By End-User
Hospitals and Clinics
Government Hospitals
Private Clinics
Diagnostic Laboratories
Independent Laboratories
Hospital-Based Laboratories
Academic and Research Institutes
By Distribution Channel
Retail Pharmacies
Standalone Pharmacies
Chain Pharmacies
Online Pharmacies
E-Commerce Platforms
Health Portals
By Geography
North America United States Canada
Europe Germany France United Kingdom
Rest of Europe
Asia Pacific China Japan India
Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
